Million Dollar Bike Ride - Lymphangioleiomyomatosis
Donate now!
Lymphangioleiomyomatosis (LAM) strikes women in the prime of their lives. Gina will join Patricia Ortiz and the LAM Easy Breathers in the Penn Medicine Million Dollar Bike Ride. Please donate to help fund the cure.
Fundraising goal $1,000.00
Recent donations (10 donations)
Name DescendingX Amount
Mr. Doug Chadwick
Mr. Bob Pellegrin $25.00
Mr. David Lewis $50.00
Ms. Ivy Richards
Mrs. Linda Walkowiak $100.00
Next
Recent donations
Top donors (10 donations)
Marie and Clark Pettibon
Mrs. Linda Walkowiak $100.00
Mr. Doug Chadwick
Anonymous
Mr. David Lewis $50.00
Next
Gina's Lucky 13

Help Gina celebrate 13 years post double lung transplant by donating to her efforts to ride 33 miles with the LAM Easy Breathers Team to fund research to find a cure for LAM. The Penn Medicine Orphan Disease Center will host the 3rd Annual Million Dollar Bike Ride on Saturday, May 7th, 2016 to raise money for rare disease research.
I Have LAM
I'm Gina Lorenzen and I was 35 years old in 1991 when I was diagnosed with lymphangioleiomatosis (LAM) a rare and fatal lung disease that strikes young women in their prime. LAM was rare, they said, only 100 known cases, no known treatment, no cure, and survival was about 10 years from diagnosis. Lung transplant could be a "last resort."

Devastated, I felt my life was over, even though I had a young son, a talented husband and a promising career. I continued to work, but it was getting harder and harder to breathe, and to cope.

Then in 1995, Sue Byrnes started The LAM Foundation promising "A Breath of Hope," for the few of us who were unlucky enough to have this fatal diagnosis. Through the foundation, I became involved in clinical research on LAM at the National Institutes of Health. Finally, there was HOPE.

Nevertheless, my disease continued to progress and by 2000, I accepted the inevitable and was listed for transplant. It was a long 41-month wait, but on September 3, 2003 I got a second chance at life as a successful recipient of a double lung transplant. I was happy to donate my diseased lungs to the NIH to further understanding of LAM and I continue to participate in LAM research however I can.

This year, on March 2, 2016, I will celebrate my 60th birthday! (which is pretty amazing because I didn't think I would see 50!) I continue to do well 25 years after my diagnosis and 13 years post transplant, thanks in no small part to the doctors and scientists who have guided me along the way.
LAM Research Has Come a Long Way
The LAM Foundation began in 1995 with a "Journey of a Thousand Miles". The roadmap that we have charted for our journey to find an effective treatment for LAM is simple: gene, protein, pathway, target, trials, and therapy. The Foundation began funding research in 1996 and the first step was achieved in 2000 with Dr. Elizabeth Henske's discovery of the importance of tuberous sclerosis genes in LAM. Dr. Vera Krymskaya then showed us in 2003 that the TSC cellular pathway was dyregulated in LAM cells from patients and that LAM cell growth was inhibited by rapamycin. Drs. Ray Yeung and David Kwiatkowski demonstrated that tumors in mice and rats with tuberous sclerosis shrunk on rapamycin, and based on his laboratory data, Dr. Richard Lamb from England first uttered the heretical suggestion that we might treat LAM patients with rapamycin. The discoveries of these LAM Foundation-funded scientists, and those of countless other partners in the tuberous sclerosis and Drosophila biology fields, has now brought our destination into focus.

Promising molecular targets that are ready for testing in clinical trials have been identified, many of which are addressable with drugs that are FDA-approved for other indications. Research funded by The LAM Foundation is therefore focused on the development and validation of drug targets, prioritization of compounds for testing, and facilitation and implementation of phase I /phase II clinical trials.
© 2016 The LAM Foundation. All Rights Reserved.
Often Misdiagnosed, LAM is Not as Rare as We Thought
Although LAM is considered to be a rare disease, researchers believe that it is not as rare as previously thought. Current estimates of the incidence of LAM are based on data from registries in the United States, France, and the United Kingdom, three countries where there have been substantial organized efforts in contacting pulmonary physicians to determine the number of patients with LAM. As previously mentioned, because LAM is relatively uncommon, it is often misdiagnosed. Therefore, the current number of women diagnosed with LAM does not accurately represent the true prevalence of the disease. Rough estimates suggest that there could be as many as 30,000 to 50,000 women worldwide who actually have sporadic LAM.
Help Gina Celebrate by Supporting Her Ride
I am so happy to be here! Join me in celebrating my 60th birthday and 13 years post double lung transplant by donating to fund research to find a cure for LAM, a cruel disease that robs young women of their breath.
I have been training all winter to be able to ride 33 miles in the Penn Med Million Dollar Bike Ride.
Donate $100, $50, $25, $10 or $5 so I can reach my goal of $1000 for LAM research.
Thank you for your consideration. Any donation is greatly appreciated.
  • $100
  • $50
  • $25
  • $10
  • $5
  • Other
Donation messages
Good luck... and big hugs.. Love, Doug and Gina --Mr. Doug Chadwick
So glad and grateful our "miracle girl" is happy, healthy and HERE--and showing us all how to live with courage, grace, a sense of adventure, joie de vivre and humor! Thank you for being a shining example. xoxo always --Ms. Ivy Richards
You are an inspiration! Love ya! --Mrs. Linda Walkowiak
I am honored to support you, Gina. Ride Strong! --Ms. Cheryl Williams
You are an inspiration Gina! Love ya --Mr. Michael Corlis
Donate!

Share this page with your friends
Post fundraising progress

delrossi@upenn.edu | Anne Marie Del Rossi, Director, Data Services | 215.898.3062
2929 Walnut Street, Suite 300 Philadelphia, PA 19104 | Superuser